Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China

Oral Oncology

Volumn 48, Issue 9, 2012, Pages 864-869

  Zhao, Li Na ^a   Zhou, Bin ^a   Shi, Mei ^a   Wang, Jian Hua ^a   Xiao, Feng ^a   Xu, Man ^a   Luo, Shan Quan ^a   Xue, Ying ^a   Li, Jian Ping ^a   Tan, Li Na ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Clinical outcome; IMRT; Nasopharyngeal carcinoma; Non endemic region; Prognostic factors; WHO type II

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER SURVIVAL; CHINA; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION INJURY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865181832     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.03.001     Document Type: Article

References (31)

1. N. Lee, P. Xia, J.M. Quivey, K. Sultanem, I. Poon, and C. Akazawa Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 1 2002 12 22 (Pubitemid 34465802)
2. N. Lee, J. Harris, A.S. Garden, W. Straube, B. Glisson, and P. Xia Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 J Clin Oncol 27 22 2009 3684 3690
3. J.A. Langendijk, C.R. Leemans, J. Buter, J. Berkhof, and B.J. Slotman The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature J Clin Oncol 22 22 2004 4604 4612 (Pubitemid 41185128)
4. H. Xiayun, D. Ou, H. Ying, G. Zhu, C. Hu, and T. Liu Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma Eur Arch Otorhinolaryngol 269 3 2012 1027 1033
5. S. Lin, J.J. Lu, L. Han, Q. Chen, and J. Pan Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases BMC Cancer 10 2010 39
6. M.K. Kam, P.M. Teo, R.M. Chau, K.Y. Cheung, P.H. Choi, and W.H. Kwan Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience Int J Radiat Oncol Biol Phys 60 5 2004 1440 1450 (Pubitemid 39601861)
7. I.W. Tham, S.W. Hee, R.M. Yeo, P.B. Salleh, J. Lee, and T.W. Tan Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre Singapore experience Int J Radiat Oncol Biol Phys 75 5 2009 1481 1486
8. M.R. Vergeer, P.A. Doornaert, D.H. Rietveld, C.R. Leemans, B.J. Slotman, and J.A. Langendijk Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program Int J Radiat Oncol Biol Phys 74 1 2009 1 8
9. S.L. Wolden, W.C. Chen, D.G. Pfister, D.H. Kraus, S.L. Berry, and M.J. Zelefsky Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience Int J Radiat Oncol Biol Phys 64 1 2006 57 62 (Pubitemid 41831209)
10. W.T. Ng, M.C. Lee, W.M. Hung, C.W. Choi, K.C. Lee, and O.S. Chan Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 79 2 2011 420 428
11. E.T. Chang, and H.O. Adami The enigmatic epidemiology of nasopharyngeal carcinoma Cancer Epidemiol Biomarkers Prev 15 10 2006 1765 1777 (Pubitemid 44664247)
12. S.H. Ou, J.A. Zell, A. Ziogas, and H. Anton-Culver Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology Ann Oncol 18 1 2007 29 35 (Pubitemid 46152495)
13. S.H. Cheng, K.L. Yen, J.J. Jian, S.Y. Tsai, N.M. Chu, and S.Y. Leu Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials Int J Radiat Oncol Biol Phys 50 3 2001 717 726 (Pubitemid 32519599)
14. J. Wang, M. Shi, Y. Hsia, S. Luo, L. Zhao, and M. Xu Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study Radiat Oncol 7 1 2012 2
15. D.L. Kwong, J.S. Sham, L.H. Leung, A.C. Cheng, W.M. Ng, and P.W. Kwong Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 64 2 2006 374 381 (Pubitemid 43083421)
16. S. Lin, J. Pan, L. Han, X. Zhang, X. Liao, and J.J. Lu Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series Int J Radiat Oncol Biol Phys 75 4 2009 1071 1078
17. D.L. Kwong, E.H. Pow, J.S. Sham, A.S. McMillan, L.H. Leung, and W.K. Leung Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function Cancer 101 7 2004 1584 1593 (Pubitemid 39318905)
18. W.W. Xiao, S.M. Huang, F. Han, S.X. Wu, L.X. Lu, and C.G. Lin Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study Cancer 117 9 2011 1874 1883
19. I.W. Tham, and J.J. Lu Controversies and challenges in the current management of nasopharyngeal cancer Expert Rev Anticancer Ther 10 9 2010 1439 1450
20. A.T. Chan Nasopharyngeal carcinoma Ann Oncol 21 Suppl. 7 2010 vii308 vii312
21. L. Chen, C.S. Hu, X.Z. Chen, G.Q. Hu, Z.B. Cheng, and Y. Sun Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial Lancet Oncol 13 2 2012 163 171
22. C.A. Perez, V.R. Devineni, V. Marcial-Vega, J.E. Marks, J.R. Simpson, and N. Kucik Carcinoma of the nasopharynx: factors affecting prognosis Int J Radiat Oncol Biol Phys 23 2 1992 271 280
23. J.M. Hwang, K.K. Fu, and T.L. Phillips Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 41 5 1998 1099 1111 (Pubitemid 28377492)
24. W.M. Sze, A.W. Lee, T.K. Yau, R.M. Yeung, K.Y. Lau, and S.K. Leung Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control Int J Radiat Oncol Biol Phys 59 1 2004 21 27 (Pubitemid 38501503)
25. M.K. Chen, T.H. Chen, J.P. Liu, C.C. Chang, and W.C. Chie Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume Cancer 100 10 2004 2160 2166 (Pubitemid 38580335)
26. F. Cheung, O. Chan, W.T. Ng, L. Chan, A. Lee, and S.W. Pang The prognostic value of histological typing in nasopharyngeal carcinoma Oral Oncol 2011 [Epub ahead of print]
27. K.J. Yu, W.L. Hsu, R.M. Pfeiffer, C.J. Chiang, C.P. Wang, and P.J. Lou Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families Clin Cancer Res 17 7 2011 1906 1914
28. W.Y. Wang, C.W. Twu, H.H. Chen, J.S. Jan, R.S. Jiang, and J.Y. Chao Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma Clin Cancer Res 16 3 2010 1016 1024
29. K.C. Chan, S.F. Leung, S.W. Yeung, A.T. Chan, and Y.M. Lo Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients Clin Cancer Res 14 15 2008 4809 4813
30. M. Al-Sarraf, M. LeBlanc, P.G. Giri, K.K. Fu, J. Cooper, and T. Vuong Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 4 1998 1310 1317 (Pubitemid 28175745)
31. B. Baujat, H. Audry, J. Bourhis, A.T. Chan, H. Onat, and D.T. Chua Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 1 2006 47 56 (Pubitemid 41831208)